Pepcid: From Poor Man’s Cure to $20M COVID-19 Trial
Remember Hydrocychloroquine?
The drug that doesn’t work for COVID-19?
Well, here’s some good news for you. A crazy rock climber/mountain rescue nut named Michael Callahan and a brilliant group of 3D modelers working nights, weekends and in between, got one that does work. This story reads like a spy novel but it’s true! (As told by Science).
It starts with…. “Inside a hospital in Wuhan, a globetrotting Infectious Disease doctor” … with, shall we say, deep biodefense connections, was examining COVID-19 patients with his Chinese physician colleagues when they noticed that poorer patients were doing better. What turned out to be protective was a cheap OTC drug for heartburn known as Pepcid (Famotidine).
It just turns out that Robert Malone, a biodefense expert and member of a classified project called DOMANE (hmmm, how do we know that?), was working with the team at MIT Lincoln Labs using artificial intelligence and 3D modeling to rapidly identify FDA-approved drugs that can be repurposed for new viruses. Of course Michael and Robert connected and a trial was swiftly coordinated, with BARDA financial backing of over $20 million USD. Now, based on this recent study, it may save the life of someone you know.
Yes, Pepcid. (Where are the trumpets, damn it!)
But the story is not over yet. Stay tuned for the dénouement.
Meanwhile, for those of us who neither globe-trotting-spy-doctors nor 3D-DARPA-scientists, but just trying to save people from death and destruction due to COVID-19 with nothing but our wits and bare hands, we have the following WEBINAR to offer you!, Please join us! |
